Phenotypic switching in Cryptococcus neoformans

Microbiology

Volumn 152, Issue 1, 2006, Pages 3-9

  Guerrero, A ^a   Jain, N ^a   Goldman, D L ^b   Fries, B C ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; POLYSACCHARIDE;

CELL WALL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODEL; FUNGAL MENINGITIS; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE EXPRESSION; IMMUNE RESPONSE; INTRACRANIAL PRESSURE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SEROTYPE; SHORT SURVEY; YEAST;

ANIMALS; BACTERIAL CAPSULES; CHRONIC DISEASE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; GENES, BACTERIAL; HUMANS; INTRACRANIAL PRESSURE; MENINGITIS, CRYPTOCOCCAL; MICE; PHAGOCYTOSIS; POLYSACCHARIDES; RATS; SELECTION (GENETICS); VARIATION (GENETICS); VIRULENCE;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; MURINAE;

EID: 30744470121     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.28451-0     Document Type: Short Survey

References (58)

1. Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Graviss, E. A., Rees, J., Spitzer, E. D., Pinner, R. W. & Mayer, L. W. (1996). Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis. Cryptococcal Disease Active Surveillance Group. J Infect Dis 174, 812-820.
2. Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Hamill, R. J., Pappas, P. G., Reingold, A. L., Rimland, D. & Warnock, D. W. (2001). Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother 45, 3065-3069.
3. Bulmer, G. S. & Sans, M. D. (1968). Cryptococcus neoformans. III. Inhibition of phagocytosis. J Bacteriol 95, 5-8.
4. Casadevall, A. & Pirofski, L. A. (1999). Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 67, 3703-3713.
5. Casadevall, A. & Pirofski, L. (2001). Host-pathogen interactions: the attributes of virulence. J Infect Dis 184, 337-344.
6. Chao, L., Vargas, C., Spear, B. & Cox, E. (1983). Transposable elements as mutator genes in evolution. Nature 303, 633-635.
7. Chen, L. C. & Casadevall, A. (1999). Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice. Clin Diagn Lab Immunol 6, 266-268.
8. Cherniak, R., Morris, L. C., Belay, T., Spitzer, E. D. & Casadevall, A. (1995). Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun 63, 1899-1905.
9. 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol 5, 146-159.
10. Currie, B., Sanati, H., Ibrahim, A. S., Edwards, J. E., Jr, Casadevall, A. & Ghannoum, M. A. (1995). Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Antimicrob Agents Chemother 39, 1934-1937.
11. Deitsch, K. W., Moxon, E. R. & Wellems, T. E. (1997). Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev 61, 281-293.
12. D'Souza, C. A. & Heitman, J. (2001). It infects me, it infects me not: phenotypic switching in the fungal pathogen Cryptococcus neoformans. J Clin Invest 108, 1577-1578.
13. Ebert, D. (1998). Experimental evolution of parasites. Science 282, 1432-1435.
14. Eissenberg, L. G., Poirier, S. & Goldman, W. E. (1996). Phenotypic variation and persistence of Histoplasma capsulatum yeasts in host cells. Infect Immun 64, 5310-5314.
15. Feldmesser, M., Kress, Y., Novikoff, P. & Casadevall, A. (2000). Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68, 4225-4237.
16. Feldmesser, M., Kress, Y. & Casadevall, A. (2001). Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147, 2355-2365.
17. Franzot, S., Mukherjee, J., Cherniak, R., Chen, L., Hamdan, J. & Casadevall, A. (1998). Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66, 89-97.
18. Fries, B. C. & Casadevall, A. (1998). Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis 178, 1761-1766.
19. Fries, B. C., Chen, F., Currie, B. P. & Casadevall, A. (1996). Karyotype instability in Cryptococcus neoformans infection. J Clin Microbiol 34, 1531-1534.
20. Fries, B. C., Goldman, D. L., Cherniak, R., Ju, R. & Casadevall, A. (1999). Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun 67, 6076-6083.
21. Fries, B. C., Taborda, C. P., Serfass, E. & Casadevall, A. (2001). Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 108, 1639-1648.
22. Fries, B. C., Cook, E., Wang, X. & Casadevall, A. (2005a). Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans. Antimicrob Agents Chemother 49, 350-357.
23. Fries, B. C., Lee, S. C., Kennan, R., Zhao, W., Casadevall, A. & Goldman, D. L. (2005b). Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis. Infect Immun 73, 1779-1787.
24. Goldman, D., Fries, B., Franzot, S., Montella, L. & Casadevall, A. (1998). Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. Proc Natl Acad Sci U S A 95, 14967-14972.
25. Guerrero, A., Jain, N., Cool, E., Casadevall, A. & Fries, B. (2003). Phenotypic switch variants of Cryptococcus neoformans differ in gene expression profile. In 103rd General Meeting of the American Society for Microbiology, Washington DC, Abstract F39.
26. Hammerschmidt, S., Hilse, R., van Putten, J., Gerady-Schahn, R., Unkmair, A. & Frosch, M. (1996). Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 15, 192-198.
27. Jain, N., Wickes, B. L., Keller, S. M., Fu, J., Casadevall, A., Jain, P., Ragan, M. A., Banerjee, U. & Fries, B. J Clin Microbiol 43, 5733-5742.
28. Klar, A. J., Srikantha, T. & Soll, D. R. (2001). A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans. Genetics 158, 919-924.
29. Kugler, S., Schurtz Sebghati, T., Groppe Eissenberg, L. & Goldman, W. E. (2000). Phenotypic variation and intracellular parasitism by Histoplasma capsulatum. Proc Natl Acad Sci U S A 97, 8794-8798.
30. Lachke, S. A., Srikantha, T., Tsai, L. K., Daniels, K. & Soll, D. R. (2000). Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP. Infect Immun 68, 884-895.
31. Levitz, S. M., Nong, S. H., Seetoo, K. F., Harrison, T. S., Speizer, R. A. & Simons, E. R. (1999). Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun 67, 885-890.
32. Lysnynansky, I., Rosengarten, R. & Yogev, D. (1996). Phenotypic switching of variable surface lipoproteins in Mycoplasma bovis involves high-frequency chromosomal rearrangement. J Bacteriol 178, 5395-5401.
33. Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W. & Deretic, V. (1993). Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A 90, 8377-8381.
34. Miller, M. G. & Johnson, A. D. (2002). White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell 110, 293-302.
35. Mirza, S. A., Phelan, M., Rimland, D. & 8 other authors (2003). The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 36, 789-794.
36. Myler, P., Allison, J., Agabian, N. & Stuart, K. (1984). Antigenic variation in African trypanosomes by gene replacement or activation of alternate telomeres. Cell 39, 203-211.
37. Perez-Martin, J., Uria, J. A. & Johnson, A. D. (1999). Phenotypic switching in Candida albicans is controlled by a SIR2 gene. EMBO J 18, 2580-2592.
38. Perfect, J. R. & Casadevall, A. (2002). Cryptococcosis. Infect Dis Clin North Am 16, 837-874, v-vi.
39. Waller, M. A., Zhang, J., Messer, S. A., Brandt, M. E., Hajjeh, R. A., Jessup, C. J., Tumberland, M., Mbidde, E K. & Ghannoum, M. A. (1999). In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 43, 169-171.
40. Pietrella, D., Fries, B., Lupo, P., Bistoni, F., Casadevall, A. & Vecchiarelli, A. (2003). Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Cell Microbiol 5, 513-522.
41. Powderly, W. G. (2000). Current approach to the acute management of cryptococcal infections. J Infect 41, 18-22.
42. Radford, D., Challacombe, S. & Walter, J. (1994). A scanning electron microscopy investigation of the structure of colonies of different morphologies produced by phenotypic switching in Candida albicans. J Med Microbiol 40, 416-423.
43. Rustchenko-Bulgac, E. (1991). Variations of Candida albicans electrophoretic karyotypes. J Bacteriology 1991, 6586-6596.
44. Schwan, T. G. & Hinnebush, B. J. (1998). Bloodstream- versus tick-associated variants of a relapsing fever bacterium. Science 280, 1938-1940.
45. Silverman, M., Zieg, J., Hilmen, M. & Simon, M. (1979). Phase variation in Salmonella: genetic analysis of a recombinational switch. Proc Natl Acad Sci U S A 76, 391-395.
46. Sinha, H., Pain, A. & Johnstone, K. (2000). Analysis of the role of recA in phenotypic switching of Pseudomonas tolaasii. J Bacteriol 182, 6532-6535.
47. Slutsky, B., Buffo, J. & Soll, D. R. (1985). High-frequency switching of colony morphology in Candida albicans. Science 230, 666-669.
48. Slutsky, B., Staebell, M., Anderson, J., Risen, L., Waller, M. & Soll, D. R. (1987). "White-opaque transition": a second high-frequency switching system in Candida albicans. J Bacteriol 169, 189-197.
49. Soll, D. R. (1992). High-frequency switching in Candida albicans. Clin Microbiol Rev 5, 183-203.
50. Soll, D. R. (2002). Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Trop 81, 101-110.
51. Soll, D., Galask, R., Isley, S., Rao, T., Stone, D., Hicks, J., Schmid, J., Mac, K. & Hanna, C. (1989). Switching of Candida albicans during successive episodes of recurrent vaginitis. J Clin Microbiol 27, 681-690.
52. Spitzer, E. D., Spitzer, S. G., Freundlich, L. F. & Casadevall, A. (1993). Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 341, 595-596.
53. Srikantha, T., Tsai, L., Daniels, K., Klar, A. J. & Soll, D. R. (2001). The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans. J Bacteriol 183, 4614-4625.
54. Steenbergen, J. N., Shuman, H. A. & Casadevall, A. (2001). Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 98, 15245-15250.
55. Sukroongreung, S., Lim, S., Tantimavanich, S., Eampokalap, B., Carter, D., Nilakul, C., Kulkeratiyut, S. & Tansuphaswadikul, S. (2001). Phenotypic switching and genetic diversity of Cryptococcus neoformans. J Clin Microbiol 39, 2060-2064.
56. Swartley, L., Marfin, A., Edupuganti, S., Liu, L., Cieslak, P., Perkins, B. & Wenger, J. (1997). Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A 94, 271-276.
57. True, H. L. & Lindquist, S. L. (2000). A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483.
58. Vargas, K., Messer, S. A., Pfaller, M., Lockhart, S. R., Stapleton, J. T., Hellstein, J. & Soll, D. R. (2000). Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol 38, 3595-3607.